Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO). (Q43505131)
Jump to navigation
Jump to search
scientific article published in July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO). |
scientific article published in July 2012 |
Statements
Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO) (English)
Miguel J Gil
Ramón de Las Peñas
Pedro Peréz-Segura
Adelaida García-Velasco
Carlos Mesia
Oscar Gallego
Concepción Fernández-Chacón
María Martínez-García
Ana Herrero
Raquel Andrés
Manuel Benavides
Teresa Quintanar
Xavier Pérez-Martin